Cannabis investment company SOL Global Investments purchased additional common shares to raise its ownership in its CBD-focused wellness subsidiary HeavenlyRx to 44.53%. As part of a larger private offering, the Toronto-based international investment company announced Monday it spent an additional $18.1 million (23.9 million Canadian dollars) on HeavenlyRx. The announcement comes just weeks after Sol […]